Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,951,839
+$492,615 QoQ
Shares Held
245,993
-10.9% QoQ
Ownership
0.462%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#45
of 182 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atom Investors LP holds $125,877,416 across 43 Biotechnology names. KALV ranks #10 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
319,316 | $16,687,454 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
107,753 | $9,042,631 | |
| 3 | CELC |
Celcuity Inc.
|
76,321 | $8,711,278 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
190,773 | $7,272,266 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
21,196 | $6,829,139 | |
| 6 | IMNM |
Immunome Inc.
|
306,880 | $6,711,465 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
158,509 | $6,295,977 | |
| 8 | ERAS |
Erasca, Inc.
|
345,587 | $5,591,597 |
All Filings in KALV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,951,839 | 245,993 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,459,224 | 276,113 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $184,407 | 16,312 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $234,433 | 19,901 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $770,959 | 65,005 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $855,589 | 69,844 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $628,704 | 65,286 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $302,031 | 33,559 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $177,510 | 22,584 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||